EUCTR2019-001009-26-BE进行中（未招募）1 期
Gastrointestinal behaviour of mesalazine in healthy volunteers
KU Leuven - Drug Delivery and Disposition0 个研究点目标入组 10 人开始时间: 2019年7月29日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •healthy volunteers age: 18 - 35 years old
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- allergy for salicylic acid derivatives - acute/chronic GI condition - diabetes, cardiovasular/pulmonary/renal diseases - use of medication (except contraception) - (possible) pregnancy - smoking - HIV / HBV / HCV infection
研究者
相似试验
进行中（未招募）
1 期
The influence of the body on the fate of mesalazine in healthy volunteersEUCTR2019-003728-19-BEKU Leuven8
进行中（未招募）
1 期
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D). - Mesalazine for the treatment of IBS-DDiarrhoea-predominant irritable bowel syndromeMedDRA version: 14.0 Level: LLT Classification code 10060849 Term: Diarrhoea predominant irritable bowel syndrome System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2010-018340-14-GBniversity of Nottingham136
已完成
不适用
Comparison of rectal with oral mesalazine in the treatment of Ulcerative Proctitis (CORRECT Study)lcerative colitisJPRN-UMIN000010340Saitama Medical Center, Saitama Medical University60
进行中（未招募）
不适用
Evaluation of the role of mesalazine in the treatment of diverticular disease of the colon and irritable colon syndrome: A randomised double blind placebo controlled clinical study - NDIrritable bowel Syndrome Diverticular disease of the colonMedDRA version: 9.1Level: LLTClassification code 10009993MedDRA version: 9.1Level: LLTClassification code 10023004EUCTR2008-004228-22-ITSOFAR SPA
招募中
不适用
In-vivo Bioequivalence study of Mezasa granules with brand drugs (PENTASA Ferring Pharmaceuticals Co, Gremany)Bio equivalence test.IRCT20200105046010N40Koushan Pharmed Pharmaceutical Company24